Last €33.81 EUR
Change Today -0.295 / -0.86%
Volume 437.0
AG8 On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 1:59 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

agilent technologies inc (AG8) Snapshot

Open
€34.38
Previous Close
€34.11
Day High
€34.52
Day Low
€33.75
52 Week High
09/18/14 - €46.45
52 Week Low
12/16/14 - €30.49
Market Cap
11.4B
Average Volume 10 Days
218.3
EPS TTM
--
Shares Outstanding
335.8M
EX-Date
01/2/15
P/E TM
--
Dividend
€0.38
Dividend Yield
1.12%
Current Stock Chart for AGILENT TECHNOLOGIES INC (AG8)

agilent technologies inc (AG8) Details

Agilent Technologies, Inc. provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company’s Life Sciences and Diagnostics segment offers liquid chromatography systems, columns, and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; nuclear magnetic resonance, magnetic resonance imaging, and X-ray diffraction systems; immunohistochemistry; in situ hybridization; hematoxylin and eosin staining; special staining, DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation and gene expression profiling; next generation sequencing target enrichment; and automated gel electrophoresis-based sample analysis systems. Its Chemical Analysis segment provides gas chromatography systems, columns, and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; inductively coupled plasma optical emission spectrometry instruments; molecular spectroscopy instruments; software and data systems; and vacuum pumps and measurement technologies. Agilent Technologies, Inc. sells its products through direct sales; and distributors, resellers, manufacturer's representatives, telesales, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.

21,400 Employees
Last Reported Date: 12/22/14
Founded in 1999

agilent technologies inc (AG8) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: $1.0M
President and Chief Operating Officer
Total Annual Compensation: $575.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $597.9K
Executive Vice President, Chief Executive Off...
Total Annual Compensation: $741.7K
Compensation as of Fiscal Year 2013.

agilent technologies inc (AG8) Key Developments

Agilent Technologies Inc. Introduces the GenetiSure Pre-Screen Kit

Agilent Technologies Inc. introduced the GenetiSure Pre-Screen Kit, a high-throughput oligonucleotide microarray for screening aneuploidy and other genomic aberrations in the 5- to 10-Mb range from single cells in three- and five-day embryos. Agilent's kit allows for a turnaround time of less than eight hours from DNA extraction to data analysis-an industry first. The kit consists of a microarray that can run up to 14 samples and two reference samples simultaneously, so more embryos can be screened without significantly increasing costs. The GenetiSure Pre-Screen array is based on Agilent's market-leading technology for high-resolution oligonucleotide comparative genomic hybridization. The kit contains all necessary reagents to enable whole-genome amplification and labeling of single cells. The microarray is compatible with Agilent's CytoGenomics software (version 3.0 or higher) for easy data analysis.

Agilent Technologies Inc. and Baylor College of Medicine Open Mass Spectrometry Center of Excellence

Agilent Technologies Inc. and Baylor College of Medicine have opened the Mass Spectrometry Center of Excellence as part of the Alkek Center for Molecular Discovery and the Baylor College of Medicine Core Laboratory in the college's department of molecular and cellular biology. Baylor and Agilent have identified several areas of mutual interest-metabolomics, lipidomics, clinical research, disease research-where both company's believe can make real progress together. Agilent is equipping the new center with two systems configured for metabolomics: an Agilent 6495 triple quadrupole LC/MS system and an Agilent 6550 iFunnel quadrupole time-of-flight LC/MS system with a switchable GC APCI interface. The systems include Mass Hunter software for qualitative and quantitative analysis as well as Mass Profiler Professional with Pathway Architect for bioinformatics and integrated multi-omic analysis. Baylor and Agilent will use the equipment collaboratively to analyze samples, conduct research and train students.

Agilent Technologies Inc.(NYSE:A) dropped from S&P 500 Growth Index

Agilent Technologies Inc.(NYSE:A) dropped from S&P 500 Growth Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AG8:GR €33.81 EUR -0.295

AG8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $49.28 USD +0.28
ARRIS Group Inc $26.66 USD -0.40
KLA-Tencor Corp $63.47 USD +0.13
NVIDIA Corp $19.61 USD -0.02
Xilinx Inc $39.20 USD -0.245
View Industry Companies
 

Industry Analysis

AG8

Industry Average

Valuation AG8 Industry Range
Price/Earnings 26.0x
Price/Sales 1.9x
Price/Book 2.4x
Price/Cash Flow 25.8x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGILENT TECHNOLOGIES INC, please visit www.home.agilent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.